Clinical trial support services are distinguishing services used by pharmaceutical companies during the clinical trials of any new drugs or molecular analysis of generics and biosimilars before their introduction in the market. Thus, with the increasing number of clinical trials across the globe, the demand for clinical trials support services is also increasing rapidly.
Market Dynamics:
Increasing prevalence of chronic/infectious disease, increase in drug discovery and development, increasing number of clinical trials, and increasing demand for clinical trials support services are major factors expected to driver growth of the global clinical trials support services market during the forecast period. For instance, According to the World Health Organization (WHO), there was a steady rise in the number of newly recruiting trials registered on the International Clinical Trials Registry Platform (ICTRP) for most WHO regions. The U.S. had a highest total number of trials registered during 1999-2022 (168,520), followed by China (94,193) and Japan (63,499).
However, stringent regulatory framework and poor healthcare infrastructure is expected to hamper the growth of the global clinical trials support services market.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook